AGIOS PHARMACEUTICALS

agios-pharmaceuticals-logo

Agios Pharmaceuticals is a biopharmaceutical company, discovers and develops therapeutics in the field of cancer metabolism. It also develops drugs that focus on glycolysis, fatty acid metabolism, and autophagy. The company's therapeutics are used in the areas of autoimmune, inflammatory, and neurological diseases. Agios Pharmaceuticals was formerly known as CANCER METABOLISM THERAPEUTICS And changed its name to Agios Pharmaceuticals In April 2008. The company is based in Cambridge, Massachusetts.

#SimilarOrganizations #People #Financial #Event #Website #More

AGIOS PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Medical Pharmaceutical

Founded:
2008-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.agios.com

Total Employee:
101+

Status:
Active

Contact:
+1 617 649 8600

Email Addresses:
[email protected]

Total Funding:
775.82 M USD

Technology used in webpage:
Apple Mobile Web Clips Icon HSTS IPv6 ReCAPTCHA Cloudflare Hosting ReCAPTCHA V2 Microsoft HSTS IncludeSubdomains PreLoad Ruby On Rails Token DigiCert SSL


Similar Organizations

alnylam-pharmaceuticals-logo

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.

aveo-oncology-logo

AVEO Oncology

AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

cstone-pharmaceuticals-logo

CStone Pharmaceuticals

CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.

fovea-pharmaceuticals-logo

Fovea Pharmaceuticals

Fovea Pharmaceuticals is a French biopharmaceutical company that discovers and develops drugs for the treatment of ocular diseases.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.

quest-pharmatech-logo

Quest PharmaTech

Quest PharmaTech is a pharmaceutical company that is developing antibody-based immunotherapeutic products for cancer.

trevarx-biomedical-logo

Trevarx Biomedical

Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.

vion-pharmaceuticals-inc-logo

Vion Pharmaceuticals Inc

Vion Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes cancer treatment technologies.


Current Advisors List

not_available_image

Joan Brugge Member of the Scientific Advisors @ Agios Pharmaceuticals
Advisor

douglas-cole_image

Douglas Cole Member of the Board of Directors @ Agios Pharmaceuticals
Board_member
2007-12-01

lewis-c-cantley_image

Lewis C. Cantley Member of the Scientific Advisory Board @ Agios Pharmaceuticals
Advisor

john-maraganore_image

John Maraganore Member of the Board of Directors @ Agios Pharmaceuticals
Board_member
2011-11-01

paul-clancy_image

Paul Clancy Member of the Board of Directors @ Agios Pharmaceuticals
Board_member
2013-09-01

robert-nelsen_image

Robert Nelsen Member of the Board of Directors @ Agios Pharmaceuticals
Board_member

craig-thompson_image

Craig Thompson Member of the Scientific Advisors @ Agios Pharmaceuticals
Advisor

pier-pandolfi_image

Pier Pandolfi Member of the Scientific Advisors @ Agios Pharmaceuticals
Advisor

Current Employees Featured

sarah-gheuens_image

Sarah Gheuens
Sarah Gheuens Chief Medical Officer @ Agios Pharmaceuticals
Chief Medical Officer
2021-09-01

james-burns_image

James Burns
James Burns Chief Legal Officer @ Agios Pharmaceuticals
Chief Legal Officer
2002-01-01

clive-patience_image

Clive Patience
Clive Patience Chief Technical Operations Officer @ Agios Pharmaceuticals
Chief Technical Operations Officer
2022-01-01

tsveta-milanova_image

Tsveta Milanova
Tsveta Milanova Chief Commercial Officer (Jan 2023) @ Agios Pharmaceuticals
Chief Commercial Officer (Jan 2023)
2022-01-01

shin-michael_image

Shin Michael
Shin Michael senior vice president, research & development @ Agios Pharmaceuticals
senior vice president, research & development

bruce-car_image

Bruce Car
Bruce Car Chief Scientific Officer @ Agios Pharmaceuticals
Chief Scientific Officer
2020-01-01

tak-mak_image

Tak Mak
Tak Mak Founders @ Agios Pharmaceuticals
Founders

matthew-weinberg_image

Matthew Weinberg
Matthew Weinberg Director, Procurement @ Agios Pharmaceuticals
Director, Procurement
2015-01-01

charlotte-newman_image

Charlotte Newman
Charlotte Newman Chief Business Officer @ Agios Pharmaceuticals
Chief Business Officer

paul-august_image

Paul August
Paul August Vice President, Genetically Defined Disease Biology @ Agios Pharmaceuticals
Vice President, Genetically Defined Disease Biology
2021-03-01

Founder


craig-thompson_image

Craig Thompson

lewis-c-cantley_image

Lewis C. Cantley

not_available_image

Shin-San Michael Su

tak-mak_image

Tak Mak

Stock Details


Company's stock symbol is NASDAQ:AGIO

Investors List

celgene_image

Celgene

Celgene investment in Series C - Agios Pharmaceuticals

flagship-ventures_image

Flagship Pioneering

Flagship Pioneering investment in Series C - Agios Pharmaceuticals

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series C - Agios Pharmaceuticals

third-rock-ventures_image

Third Rock Ventures

Third Rock Ventures investment in Series C - Agios Pharmaceuticals

celgene_image

Celgene

Celgene investment in Series B - Agios Pharmaceuticals

flagship-ventures_image

Flagship Pioneering

Flagship Pioneering investment in Series A - Agios Pharmaceuticals

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series A - Agios Pharmaceuticals

third-rock-ventures_image

Third Rock Ventures

Third Rock Ventures investment in Series A - Agios Pharmaceuticals

Key Employee Changes

Date New article
2022-12-06 Agios Appoints Tsveta Milanova as Chief Commercial Officer
2022-07-13 Agios appoints Brian Goff as new CEO

Official Site Inspections

http://www.agios.com Semrush global rank: 2.93 M Semrush visits lastest month: 5.44 K

  • Host name: 83.162.211.130.bc.googleusercontent.com
  • IP address: 130.211.162.83
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Agios Pharmaceuticals"

Agios Announces Evolution of Research Organization

May 16, 2022 Such forward-looking statements include those regarding Agios’ plans, strategies and expectations for the preclinical, clinical and commercial advancement of its drug …See details»

Agios Pharmaceuticals - Wikipedia

Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for …See details»

Agios Pharmaceuticals - LinkedIn

Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies ...See details»

Agios Announces Evolution of Research Organization

May 16, 2022 Agios plans to reduce up to 50 roles focused on exploratory research, while retaining a strong internal research team focused on roles critical to advancing the company’s …See details»

About Us – Agios

Agios was founded in 2008 to unlock a new field of discovery in cellular metabolism. This singular focus on metabolic disease has taken us from the development of precision therapies in oncology to pioneering new …See details»

Agios Announces New Commercial Leadership Structure

CAMBRIDGE, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic …See details»

Agios Pharmaceuticals - Organisation Profile - Lix

Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing …See details»

Agios Pharmaceuticals - businessabc

Jun 12, 2025 Agios Pharmaceuticals was founded in 2007 and made its debut on the NASDAQ in July 2013. Its research and development program has advanced rapidly, and the company …See details»

Agios Pharmaceuticals Mission, Benefits, and Work …

Come see what’s going on inside Agios Pharmaceuticals, including the company culture, employee work-life benefits, and business goals. Discover all the key insights that make people want to work here. Read about the office locations, …See details»

Corporate Governance – Agios Pharmaceuticals, Inc.

The Investor Relations website contains information about Agios Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.See details»

Leadership – Agios

At Agios, leadership means building stronger bonds with colleagues, partners and patient communities and honoring each of their perspectives to make the process of developing life …See details»

Values – Agios

At Agios, our shared values and community-centric culture cultivate an environment that promotes collaboration, contribution, engagement and high regard for others’ points of view.See details»

Culture – Agios

At Agios, this deep sense of caring is what drives every person on our team and enables us to do meaningful work on behalf of people with rare diseases. It is central to our people …See details»

Pipeline – Agios

Agios has a proven track record of leveraging our expertise in cellular metabolism to develop new therapies and bring innovative medicines to patients in need. Building on our core capabilities, …See details»

Corporate Social Responsibility – Agios

It codifies Agios’s commitment to doing business in an ethical manner and in compliance with all applicable laws, regulations and industry standards. The Code helps guide our daily …See details»

Welcome to myAgios Patient Support Services

Welcome to myAgios Patient Support Services, a custom support program for people living with pyruvate kinase (PK) deficiency and those prescribed PYRUKYND® (mitapivat). Please see …See details»

Servier to Acquire Agios Pharmaceuticals’ Oncology Business

“The strategic acquisition of Agios’ oncology business, including its precision medicine portfolio and pipeline, is aligned with our ambition to become a recognized player in oncology and …See details»

Agios Reports Second Quarter 2025 Financial Results and Provides ...

1 day ago Conference Call Information Agios will host a conference call and live webcast today at 8:00 a.m. ET to discuss the company’s second quarter 2025 financial results and recent …See details»

Earnings call transcript: Agios Pharm Q2 2025 earnings miss EPS, …

1 day ago Agios Pharmaceuticals reported its Q2 2025 earnings, revealing a larger-than-expected loss per share and a notable revenue beat. The company posted an EPS of -$1.93, …See details»

Agios Announces Key 2025 Milestones for Innovative Rare Disease ...

Jan 13, 2025 The Investor Relations website contains information about Agios Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.See details»

linkstock.net © 2022. All rights reserved